MAsS Scan as a Predictor of Morbidity and Mortality in Patients With Liver Disease
- Conditions
- Liver Diseases
- Registration Number
- NCT05264051
- Lead Sponsor
- University of Chicago
- Brief Summary
The purpose of the study is to study the muscle assessment score (MAsS, utilizing MRI, as an objective measure of frailty and muscle composition to serve as a predictor of morbidity and mortality in patients with liver disease.
- Detailed Description
Prospective study of patients seen at the Univ. of Chicago Medical Center hospital and ambulatory clinics. The assessment of the MAsS score will require an additional 8-10 minutes in the MRI for each patient already undergoing MRI exam.
Four groups of pts. who are already scheduled for MRI for routine clinical purposes will be evaluated.
1. Pts. hospitalized with acute hepatic decompensation for whom MRI is otherwise indicated for clinical evaluation.
2. Pts. with hepatobiliary neoplasia
3. Pts.undergoing transjugular portosystemic shunt (TIPS) placement
4. Pts. with chronic liver disease undergoing magnetic resonance elastography for routine monitoring
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1200
- Patients who are already scheduled for an MRI for routine clinical purposes will be evaluated
- <18 yrs. of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Waitlist Mortality Measured up to 10 years out from enrollment Death prior to liver transplant or delisting from enrollment in the study
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The University of Chicago
🇺🇸Chicago, Illinois, United States